Years Without Diagnosis: The Reality of Rare Neurological Disorders in India

Add as a preferred source on Google

For many patients in India with rare neurological disorders, the most distressing aspect of illness is not only the symptoms, but the prolonged absence of a diagnosis. Years may pass before a unifying explanation is identified, during which patients move between providers, undergo repeated investigations, and receive fragmented, symptom-based treatment.

We spoke to Dr Sheetal Sharda, Director-Clinical Genomics Development and Implementation, who explained the reality of rare neurological disorders in India.

Symptoms That Often Go Unrecognised

Photo Credit: Freepik

These cases are far from uncommon. "Children and adults may present with unexplained seizures, progressive muscle weakness, developmental delay, cognitive decline, movement disorders, or fluctuating neuropsychiatric symptoms, which may frequently mimic more common conditions and end up being treated for epilepsy, cerebral palsy, primary psychiatric illness, or nonspecific neurodegeneration before the underlying cause is recognised," said Dr Sharda.

The 'Diagnostic Odyssey'

The extended search for answers: the "diagnostic odyssey," reflects the intrinsic complexity of rare neurological disorders. Many such disorders arise from genetic, metabolic, mitochondrial, or autoimmune mechanisms. "Their presentations may evolve over time, involve multiple organ systems, or initially appear nonspecific. Without early suspicion, investigations remain sequential rather than strategic, leading to repeated imaging, empirical therapies, and inconclusive laboratory workups," added Dr Sharda.

The Cost of Delayed Diagnosis

The consequences are substantial. Clinicians are limited in their ability to initiate disease-modifying therapies without diagnostic confirmation. Families face financial strain from recurrent consultations and tests, emotional exhaustion from uncertainty, and difficulty planning for the future.

"In paediatric neurology, the implications are especially significant. Timely diagnosis of inherited metabolic disorders, channelopathies, leukodystrophies, or immune-mediated encephalitis can alter developmental trajectories through targeted interventions, dietary modification, immunotherapy, or anticipatory management of complications. Delayed recognition may result in irreversible neurological decline," warned Dr Sharda.

Recognising the Red Flags

Photo Credit: Freepik

Improving outcomes begins with recognising clinical red flags. Drug-resistant epilepsy, developmental regression after a period of normal growth, multi-system involvement, episodic deterioration triggered by metabolic stress, positive family history, or consanguinity should prompt consideration of advanced testing strategies.

"Similarly, autoimmune encephalitis may initially manifest as acute psychiatric disturbance, and early antibody testing can dramatically change prognosis when immunotherapy is introduced promptly. Early molecular testing and metabolic evaluation in selected patients increasingly demonstrate higher diagnostic yield than prolonged stepwise testing," added Dr Sharda.

Why a Definitive Diagnosis Matters

A definitive diagnosis represents more than a label; it reorients care. It informs precision treatment strategies, rehabilitation planning, prognostic counselling, and surveillance for systemic complications. It enables genetic counselling and reproductive planning for families and provides access to rare disease registries, support networks, and emerging clinical trials. Even in the absence of curative therapy, diagnostic clarity allows structured management rather than reactive symptom control.

Challenges in the Indian Healthcare System

Within the Indian healthcare landscape, structural challenges persist: uneven access to specialised diagnostics, cost constraints, limited awareness at primary levels of care, and fragmented referral pathways. "Addressing these gaps requires clinician education on early warning signs, standardised referral algorithms in tertiary and paediatric centres, expanded laboratory infrastructure for genomic and metabolic testing, and multidisciplinary collaboration among neurologists, geneticists, laboratory specialists, and rehabilitation experts," emphasised Dr Sharda.

The Need for Earlier Recognition

Dr Sharda concluded, "As diagnostic technologies advance, the central challenge is no longer feasibility but timely recognition. Each year without diagnosis represents not merely clinical delay, but a missed opportunity for intervention, informed decision-making, and psychosocial support. Strengthening early suspicion and systematic evaluation is essential to shorten the diagnostic journey for patients living with rare neurological disorders in India."

Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.